Clinical Trials
All Clinical Trials - Page 50 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02099084Phase 4Completed
Short Bowel Syndrome and Teduglutide Versus Placebo
Teduglutide
- NCT02125188Phase 4Completed
Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery
Desmopressin
- NCT02022254Phase 1Completed
Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
Semaglutide
- NCT02043054Phase 3Completed
Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Liraglutide
- NCT02016911Phase 1Completed
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
Semaglutide
- NCT02014259Phase 1Completed
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
Semaglutide
- NCT01885208Phase 3Completed
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
Semaglutide
- NCT01907854Phase 4Completed
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Liraglutide
- NCT02059564Phase 1Unknown
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Liraglutide
- NCT02008682Phase 4Completed
The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
Liraglutide
- NCT02020616Phase 1/Phase 2Terminated
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Exenatide
- NCT01910194Phase 2Completed
Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
Lixisenatide
- NCT02020629Phase 4Completed
Study on Lixisenatide and Counterregulation to Hypoglycemia
Lixisenatide
- NCT01886287Phase 2Terminated
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
Octreotide
- NCT02084342N/AUnknown
Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery
Desmopressin
- NCT01982760Phase 2Terminated
DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
Desmopressin
- NCT01821846N/ACompleted
Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT01952080Phase 3Completed
A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
Teduglutide
- NCT01957436Phase 3Active Not Recruiting
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
Gonadorelin
- NCT01982630Phase 1Completed
Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
Liraglutide
- NCT02001363N/AUnknown
Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
Liraglutide
- NCT01836523Phase 3Completed
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
Liraglutide
- NCT01761318Phase 4Completed
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
Liraglutide
- NCT01988545N/AUnknown
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
Exenatide
- NCT02308254Phase 1/Phase 2Unknown
Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
Lixisenatide
- NCT01960179Phase 3Completed
Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
Lixisenatide
- NCT02166437N/AUnknown
Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese
Teriparatide
- NCT02217800Phase 2Completed
The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics
Octreotide
- NCT03771326Phase 3Completed
KP-10 and Insulin Secretion in Men
Kisspeptin
- NCT01940770N/ACompleted
Specific Clinical Experience Investigation for Long-term Use of Bydureon.
Exenatide
- NCT01954147Phase 1/Phase 2Unknown
Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
Liraglutide
- NCT01973231Phase 4Completed
Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
Liraglutide
- NCT02092597Phase 4Completed
Safety Evaluation of Adverse Reactions in Diabetes
Exenatide
- NCT02571140Phase 1Completed
A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
Teriparatide
- NCT01952145Phase 3Completed
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT01942369N/ACompleted
A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months
Gonadorelin
- NCT01674140Phase 3Active Not Recruiting
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Gonadorelin
- NCT01956851N/ACompleted
Association of Kisspeptin Levels With Insulin Secretion in Diabetes Mellitus
Kisspeptin
- NCT02128334N/ACompleted
An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
Gonadorelin
- NCT01928329Phase 2Completed
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Exenatide
- NCT01940965Phase 3Completed
Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
Lixisenatide
- NCT01913834Phase 1Unknown
Nasally and sc Administered Teriparatide in Healthy Volunteers
Teriparatide
- NCT02194452N/AWithdrawn
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Octreotide
- NCT01950403Phase 1Completed
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
Linaclotide
- NCT05561647N/ARecruiting
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
Teduglutide
- NCT01921504N/AUnknown
Effect of Acupuncture on Patients With Functional Dyspepsia: a Multi-center, Randomized, Waitlist-controlled Trial
Ghrp-6
- NCT02366247Phase 3Unknown
Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B
Thymosin-Alpha-1
- NCT01762943N/ACompleted
Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition
Gonadorelin
- NCT01916174Phase 1Completed
A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
Liraglutide
- NCT01890993N/ACompleted
Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe
Liraglutide